Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

ERCC6L2 Disease and Shwachman-Diamond Syndrome Exhibit Alterations in Metabolomes in Patient Fibroblasts

Ilse Kaaja, Suvi Douglas, Anni I Nieminen, Eija Pirinen, Ulla Wartiovaara-Kautto, Outi Kilpivaara

Blood (2023) 142 (Supplement 1): 5664.

https://doi.org/10.1182/blood-2023-173924

Published: 2023

Journal Articles

The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia

Blood (2023) 141 (23): 2853–2866.

https://doi.org/10.1182/blood.2022019425

Published: 2023

Includes: Supplemental data

Journal Articles

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia

Blood (2023) 141 (13): 1610–1625.

https://doi.org/10.1182/blood.2021011094

Published: 2023

Includes: Supplemental data

Journal Articles

Subsequent Malignant Neoplasms after Primary Hematological Malignancy in Adult Patients (Aged ≥20 Years) - High Risk of Hodgkin Lymphoma in Patients with Chronic Lymphocytic Leukemia

Rosa Rönkkö, Aapeli Nevala, Outi Kilpivaara, Janne Pitkäniemi, Nea Malila, Ulla Wartiovaara-Kautto

Blood (2022) 140 (Supplement 1): 9439–9440.

https://doi.org/10.1182/blood-2022-165168

Published: 2022

Journal Articles

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study

Patrice Chevallier, Thibault Leguay, Rathana KIM, Marc Delord, Michael Doubek, Francoise Huguet, Aurelie Cabannes-Hamy, Ulla Wartiovaara-Kautto, Colombe Saillard, Emmanuel Raffoux, Thomas Cluzeau, Stephane Lepretre, Marie Balsat, Anna Berceanu, Nicolas Boissel, Claude Gardin, Emmanuelle Clappier, Herve Dombret, Philippe Rousselot

Blood (2022) 140 (Supplement 1): 6114–6116.

https://doi.org/10.1182/blood-2022-166035

Published: 2022

Journal Articles

Erythroid/Megakaryocytic Differentiation Confers BCL-XL Dependency and Venetoclax Resistance in Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 101–103.

https://doi.org/10.1182/blood-2022-158694

Published: 2022

Journal Articles

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy Provides Very Good Outcome in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: First Results from the EWALL-INO Study

Patrice Chevallier, Thibault Leguay, Michael Doubek, Francoise Huguet, Cyril Salek, Aurélie Cabannes, Ulla Wartiovaara-Kautto, Colombe Saillard, Emmanuel Raffoux, Thomas Cluzeau, Stéphane Leprêtre, Marie Balsat, Anna Berceanu, Nicolas Boissel, Emmanuelle Clappier, Laure Morisset, Claude Gardin, Hervé Dombret, Philippe Rousselot

Blood (2021) 138 (Supplement 1): 511.

https://doi.org/10.1182/blood-2021-148625

Published: 2021

Journal Articles

Multinational Study on the Clinical and Genetic Features of the ERCC6L2-Disease

Marja Hakkarainen, Suvi P. M. Douglas, Tom Vulliamy, Inderjeet Dokal, Jean Soulier, Lise Larcher, Riitta Niinimäki, Timo Siitonen, Eva Hellstrom Lindberg, Gisela Barbany, Bianca Tesi, Amir Asher Kuperman, Hannah Tamary, Sharon Jackson, Outi Kilpivaara, Ulla Wartiovaara-Kautto

Blood (2021) 138 (Supplement 1): 864.

https://doi.org/10.1182/blood-2021-145039

Published: 2021

Journal Articles

Germline Gene Aberrations Are Common in High-Risk Adult and Pediatric Acute Lymphoblastic Leukemia Patients

Suvi Douglas, MSc, Atte Lahtinen, BM, Jessica Koski, BSc, Lilli Leimi, MD, Mikko A Keränen, MD PhD, Kimmo Porkka, Caroline A Heckman, PhD, Kirsi Jahnukainen, MD PhD, Outi Kilpivaara, PhD, Ulla Wartiovaara-Kautto, MD PhD

Blood (2019) 134 (Supplement_1): 1472.

https://doi.org/10.1182/blood-2019-126657

Published: 2019

Journal Articles

Asparaginase-Associated Pancreatitis in ALL: Results from the NOPHO ALL2008 Treatment of Patients 1-45 Years

Blood (2019) 134 (Supplement_1): 3820.

https://doi.org/10.1182/blood-2019-122275

Published: 2019

Journal Articles

ERCC6L2 defines a novel entity within inherited acute myeloid leukemia

Suvi P. M. Douglas, Pihla Siipola, Panu E. Kovanen, Marja Pyörälä, Sakari Kakko, Eeva-Riitta Savolainen, Urpu Salmenniemi, Katri Orte, Soili Kytölä, Esa Pitkänen, Kimmo Porkka, Outi Kilpivaara, Ulla Wartiovaara-Kautto

Blood (2019) 133 (25): 2724–2728.

https://doi.org/10.1182/blood-2019-01-896233

Published: 2019

Includes: Supplemental data

Journal Articles

Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

Blood (2018) 131 (22): 2475–2484.

https://doi.org/10.1182/blood-2018-01-827949

Published: 2018

Includes: Supplemental data

Journal Articles

Insights into Hematopoiesis in GATA2 Deficiency Using Single-Cell Transcriptomics

Elina A.M. Hirvonen, MSc, Inari Natri, MB, Mattila Pirkko, PhD, Jenni Lahtela, PhD, Pitkänen Esa, PhD, Ulla Wartiovaara-Kautto, MD PhD, Outi Kilpivaara, PhD

Blood (2017) 130 (Supplement 1): 2478.

https://doi.org/10.1182/blood.V130.Suppl_1.2478.2478

Published: 2017

Journal Articles

Thromboembolism in ALL Patients 1-45 Years Treated According to the NOPHO-ALL 2008 Protocol

Cecilie Rank, MD, Nina Toft, MD PhD, Ruta Tuckuviene, MD PhD, Kathrine Grell, PhD, Ove Juul Nielsen, MD DMSc, Thomas Leth Frandsen, MD PhD, Ulf Tedgaard, MD PhD, Helene Hallböök, MD PhD, Ellen Ruud, MD PhD, Petter Quist-Paulsen, MD PhD, Kaisa Vepsäläinen, MD, Ulla Wartiovaara-Kautto, MD PhD, Ólafur G. Jónsson, MD, Sonata Saulyte Trakymiene, MD, Laimonas Griškevičius, MD PhD, Kadri Saks, MD, Mari Punab, MD, Kjeld Schmiegelow, MD DMSc

Blood (2017) 130 (Supplement 1): 2564.

https://doi.org/10.1182/blood.V130.Suppl_1.2564.2564

Published: 2017

Journal Articles

Aspariginase-Triggered Hyperglycerimedia: An Analysis on Germline Regulatory Gene Variations in Adult Acute Lymphoblastic Leukemia Patients

Sari Kytölä, MD, Suvi Rantamo, MSc, Matti Jauhiainen, PhD, Kimmo Porkka, MD PhD, Outi Kilpivaara, PhD, Ulla Wartiovaara-Kautto, MD PhD

Blood (2017) 130 (Supplement 1): 1287.

https://doi.org/10.1182/blood.V130.Suppl_1.1287.1287

Published: 2017

Journal Articles

A Novel Homozygous CTC1 Germline Mutation Associated with Bone Marrow Failure

Ulla Wartiovaara-Kautto, MD PhD, Elina A. M. Hirvonen, MSc, Kaisa Kettunen, PhD, Anna Nordberg, PhD, Janna Saarela, MD PhD, Kimmo Porkka, MD PhD, Tero Kivelä, MD PhD, Tarja Linnankivi, MD PhD, Outi Kilpivaara, PhD

Blood (2016) 128 (22): 1508.

https://doi.org/10.1182/blood.V128.22.1508.1508

Published: 2016

Journal Articles

Early MRD-Negativity May Predict for Favorable Outcome Irrespective of Allotransplantation in TKI-Treated Patients with Ph-Positive Acute Lymphoblastic Leukemia

Helena Hohtari, MD, Marjatta Sinisalo, Tapio Nousiainen, MD PhD, Perttu Koskenvesa, MD, Ulla Wartiovaara-Kautto, MD PhD, Satu Mustjoki, MD PhD, Pirjo Koistinen, MD PhD, Marjaana Säily, MD PhD, Maija Itälä-Remes, Erkki Elonen, MD PhD, Kari Remes, MD PhD, Kimmo Porkka, MD PhD

Blood (2016) 128 (22): 1598.

https://doi.org/10.1182/blood.V128.22.1598.1598

Published: 2016

Journal Articles

Exchange Transfusion in Newborn Infants Activates Coagulation and Alters the Coagulation Profile.

Satu Hyytiäinen, MD, Ulla Wartiovaara-Kautto, MD, PhD, Sture Andersson, MD, PhD, Markku Heikinheimo, MD, PhD, Jari Petäjä, MD, PhD

Blood (2005) 106 (11): 953.

https://doi.org/10.1182/blood.V106.11.953.953

Published: 2005

Journal Articles

Factor V Leiden Mutation Enhances Thrombin Formation in Healthy Newborn Infants.

Satu Hyytiäinen, M.D., Veli-Matti Ulander, M.D., Ulla Wartiovaara-Kautto, M.D., Ph.D., Risto Kaaja, M.D., Ph.D., Markku Heikinheimo, M.D., Ph.D., Jari Petäjä, M.D., Ph.D.

Blood (2004) 104 (11): 3968.

https://doi.org/10.1182/blood.V104.11.3968.3968

Published: 2004

NARROW

ERCC6L2 Disease and Shwachman-Diamond Syndrome Exhibit Alterations in Metabolomes in Patient Fibroblasts

The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia

Subsequent Malignant Neoplasms after Primary Hematological Malignancy in Adult Patients (Aged ≥20 Years) - High Risk of Hodgkin Lymphoma in Patients with Chronic Lymphocytic Leukemia

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study

Erythroid/Megakaryocytic Differentiation Confers BCL-XL Dependency and Venetoclax Resistance in Acute Myeloid Leukemia

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy Provides Very Good Outcome in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: First Results from the EWALL-INO Study

Multinational Study on the Clinical and Genetic Features of the ERCC6L2-Disease

Germline Gene Aberrations Are Common in High-Risk Adult and Pediatric Acute Lymphoblastic Leukemia Patients

Asparaginase-Associated Pancreatitis in ALL: Results from the NOPHO ALL2008 Treatment of Patients 1-45 Years

ERCC6L2 defines a novel entity within inherited acute myeloid leukemia

Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

Insights into Hematopoiesis in GATA2 Deficiency Using Single-Cell Transcriptomics

Thromboembolism in ALL Patients 1-45 Years Treated According to the NOPHO-ALL 2008 Protocol

Aspariginase-Triggered Hyperglycerimedia: An Analysis on Germline Regulatory Gene Variations in Adult Acute Lymphoblastic Leukemia Patients

A Novel Homozygous CTC1 Germline Mutation Associated with Bone Marrow Failure

Early MRD-Negativity May Predict for Favorable Outcome Irrespective of Allotransplantation in TKI-Treated Patients with Ph-Positive Acute Lymphoblastic Leukemia

Exchange Transfusion in Newborn Infants Activates Coagulation and Alters the Coagulation Profile.

Factor V Leiden Mutation Enhances Thrombin Formation in Healthy Newborn Infants.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only